Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A Bardet-Biedl syndrome that has material basis in homozygous mutation in the BBS1 gene on chromosome 11q13.
Features include always present findings: Astigmatism, Abdominal obesity, Nystagmus, and Rod-cone dystrophy and others; and very common findings: Truncal obesity and Obesity. 62 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 9 | Strabismus, Cataract, Nystagmus |
BBS1 encodes Bardet-Biedl syndrome 1 (593 aa). The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. Highest expression in Ovary (53.0 TPM) and Uterus (49.1 TPM).
Bardet-Biedl syndrome 1 is associated with mutations in the BBS1 gene on chromosome 11.
The BBS1 protein participates in ARL6:GTP and the BBSome bind ciliary cargo and BBSome-mediated cargo-targeting to cilium pathways.
BBS1 is classified as a druggable target with score 3.3.
Genetic testing for BBS1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 16 always present features, 2 very common features, 7 common features.
5 clinical trials registered, 3 recruiting. Interventions under study include other interventions and gene therapy. Pipeline includes 1 EARLY_PHASE1, 1 NA. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT02435940](https://clinicaltrials.gov/study/NCT02435940) |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 6:56 PM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about Bardet-Biedl syndrome 1
7 |
Ataxia, Gait imbalance, Specific learning disability |
Arms and legs | 6 | Short foot, Radial deviation of finger, Broad foot |
Hormones | 5 | Nephrogenic diabetes insipidus, Diabetes mellitus, Insulin resistance |
Digestive system | 3 | Abdominal obesity, Liver scarring (fibrosis) (hepatic fibrosis), Biliary tract abnormality |
Head and neck | 3 | High, narrow palate, High palate, Macrocephaly |
Kidneys and urinary system | 2 | Nephrogenic diabetes insipidus, Abnormality of the kidney |
Bones and joints | 2 | Bone spicule pigmentation of the retina, Sideways curvature of the spine (scoliosis) |
Heart and blood vessels | 2 | Hypertension, Thickened left heart wall (left ventricular hypertrophy) |
Ears | 1 | Hearing loss (hearing impairment) |
Skin | 1 | Dermatochalasis |
Lungs and breathing | 1 | Asthma |
Inherited Retinal Degenerative Disease Registry
— |
Foundation Fighting Blindness |
RECRUITING |
[NCT02329210](https://clinicaltrials.gov/study/NCT02329210) | Clinical Registry Investigating Bardet-Biedl Syndrome | — | Marshfield Clinic Research Foundation | RECRUITING |
[NCT07269665](https://clinicaltrials.gov/study/NCT07269665) | First-in-Human, Dose Escalation Trial of AXV-101 in BBS1-Related Retinal Degeneration | EARLY_PHASE1 | Axovia Therapeutics | UNKNOWN |
[NCT04461444](https://clinicaltrials.gov/study/NCT04461444) | COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional Study | NA | University Hospital, Strasbourg, France | RECRUITING |
[NCT06239064](https://clinicaltrials.gov/study/NCT06239064) | Early Genetic Identification of Obesity | — | Rolfs Consulting und Verwaltungs-GmbH (RCV) | ACTIVE_NOT_RECRUITING |
3 publications have been identified in PubMed for Bardet-Biedl syndrome 1. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Epidemiology / Natural History (33%).
Mahler EA (2026). [PMID: 41238926](https://pubmed.ncbi.nlm.nih.gov/41238926/). *Die Ophthalmologie*. [Review / Meta-Analysis]
Ercoskun P (2025). [PMID: 39731278](https://pubmed.ncbi.nlm.nih.gov/39731278/). *Clinical genetics*. [Epidemiology / Natural History]
Francisco MF (2025). [PMID: 40425225](https://pubmed.ncbi.nlm.nih.gov/40425225/). *BMJ case reports*. [Case Report / Case Series]
AI-curated news mentioning Bardet-Biedl syndrome 1
Updated Sep 3, 2026
A recent study identifies multi-omics signatures associated with Alström and Bardet-Biedl syndromes through integrated oral microbiome and metabolome profiling. This research could pave the way for new diagnostic and therapeutic strategies for these rare diseases.
A recent study published in PubMed details the clinical, genetic, and endocrine features of Bardet-Biedl Syndrome across pediatric and adult cohorts. This research enhances understanding of the disease's manifestations and may inform future therapeutic strategies.
A recent study published in PubMed explores health-related quality of life, executive functioning, and eating behaviors in adults with Bardet-Biedl syndrome. This research provides insights into the daily challenges faced by this patient population.